Cellular health
Cellular health

NAD+ & Glutathione

NAD+ injectionNAD+ nasal sprayGlutathione injectionGlutathione nasal spray

Metabolic

MetforminLow dose naltrexone

Lipotropics & Energy

MICC-B12Lipo+ B6
Peptides
Peptides

Growth & recovery

Sermorelin injectionSermorelin lozenge

Skin & wellness

GHK-cu cream
Weight management
Weight management

GLP-1 — injectable

Mounjaro® (tirzepatide)Zepbound® (tirzepatide)Ozempic® (semaglutide)Wegovy® (semaglutide)

GLP-1 — oral

Wegovy® pill (semaglutide)Foundayo™ (orforglipron)
How it works
Sign in + Get started
Home Protocols Wegovy® (semaglutide)
Wegovy® (semaglutide)
Weight management

Wegovy® (semaglutide)

Prefilled pen, subcutaneous

From $580/mo*

A once-weekly GLP-1 treatment that helps control appetite and support lasting weight loss.

  • Acts on appetite-regulating pathways: helps reduce hunger and calorie intake.
  • Supports sustained weight loss: FDA-approved to help eligible adults lose weight and keep it off.
  • Reduces cardiovascular risk: FDA approved to lower the risk of major cardiovascular events in adults with established cardiovascular disease and obesity or overweight.
Get started

*Billed every 3 months, paid upfront.

Includes provider review · Ships in 3–5 days if prescribed

  • Licensed providers
  • Free shipping
  • US-based pharmacies

Wegovy® is an FDA-approved branded prescription medication dispensed by a licensed pharmacy; it is not compounded. It is prescribed only if a licensed provider determines it is clinically appropriate following an evaluation. Elysium Health is not a clinical provider but contracts with third-party clinical entities with licensed health care providers which provide medical care to individuals that use the Elysium Health platform. Image for illustration only; actual product may vary.

Safety info: Wegovy is used to treat obesity or overweight with weight-related health conditions, along with diet and exercise. It may cause serious side effects, including possible thyroid tumors. Do not use if you or your family have a history of medullary thyroid carcinoma (MTC), or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). See important safety information.

Why Wegovy®

Once-weekly GLP-1 treatment for weight management

14.9 % average body weight lost in a 68-week clinical trial *

Semaglutide is a GLP-1 receptor agonist. It acts on pathways involved in appetite and food intake, and is FDA-approved for chronic weight management alongside a reduced-calorie diet and increased physical activity.

Select your current weight 220 lbs
Weight you could lose 33 lbs

*Based on a 68-week clinical trial of adults without type 2 diabetes who had obesity, or overweight with at least one weight-related condition, in which participants taking Wegovy® 2.4 mg lost an average of 14.9% of their body weight, compared with 2.4% for participants taking placebo. All participants followed a reduced-calorie diet and increased physical activity. Individual results vary.

Get started

Illustrative calculator based on published Phase 3 trial averages; it is not a prediction or guarantee of individual results. Individual responses vary from person to person; no specific outcomes are guaranteed.

How Wegovy® works

What it does in the body

Semaglutide mimics a hormone your body already makes, under a licensed provider's plan.

Mimics a natural hormone

Semaglutide mimics GLP-1, a hormone involved in appetite and blood sugar regulation.

Supports appetite regulation

It may help you feel fuller and reduce appetite, which supports weight management for some people, with provider guidance and healthy habits.

Provider-guided

Used within a licensed-provider plan alongside diet and activity.

Our medical team

Developed with expert clinicians

Omar Baker, M.D., F.A.A.P., Elysium Chief Medical Officer

From our Chief Medical Officer

The goal of longevity treatment is not simply more years. It is more good years. We built TELI to bring clinical rigor to a space that has too often lacked it, so people can pursue their healthspan with the same confidence they bring to the rest of their medical care.
Omar Baker, M.D., F.A.A.P., Elysium Chief Medical Officer

How The Elysium Longevity Institute works

From intake to your doorstep

  1. Completing a TELI intake from home
    Step 1

    Complete your medical intake

    Choose your protocol, then share your health history and goals to begin your longevity care.

    What your provider needs

  2. A licensed provider reviewing an intake
    Step 2

    Provider review

    A licensed provider will review your intake and prescribe a personalized protocol, if appropriate.

    Licensed & confidential

  3. A TELI shipment on a doorstep
    Step 3

    Shipped to your door

    If prescribed, a licensed partner pharmacy will ship to your door free of charge within 3–5 business days.

    Fast, free shipping

  4. Messaging a provider through the TELI portal
    Step 4

    Ongoing care

    Message your provider any time through your TELI portal.

    On-demand support

+Get started today

FAQ

Frequently asked questions

What is Wegovy®?

Wegovy® is an FDA-approved prescription GLP-1 medication containing semaglutide. Along with a reduced-calorie diet and increased physical activity, it is used to help eligible adults with obesity or overweight lose weight and keep it off.

How is the Wegovy® injection different from the Wegovy® pill?

Both contain the same active ingredient, semaglutide. The Wegovy® pill is taken by mouth once daily, while the injection is administered once weekly. Your provider will determine which option is appropriate for you.

How do you take Wegovy® injections?

Wegovy® is injected under the skin once weekly using a prefilled pen. If prescribed, your provider and pharmacy will give you specific dosing and administration instructions.

What are the side effects of Wegovy®?

Common side effects include nausea, diarrhea, vomiting, constipation, stomach pain, bloating, and indigestion. These effects are often more noticeable when starting treatment or increasing your dose and may improve as your body adjusts. Contact your healthcare provider if any side effect is severe, persistent, or bothersome.

Who shouldn’t take Wegovy®?

Wegovy® should not be used by people with a personal or family history of medullary thyroid carcinoma (MTC), those with multiple endocrine neoplasia syndrome type 2 (MEN 2), or anyone who has had a serious allergic reaction to semaglutide or another ingredient in Wegovy®. Wegovy® is not recommended for people with severe gastroparesis. Tell your provider if you are pregnant or planning to become pregnant, take insulin or certain diabetes medications, or have a history of pancreas, gallbladder, kidney, or diabetic eye problems. Stop at least 2 months before a planned pregnancy.

Is Wegovy® compounded?

No. Wegovy® is a branded, FDA-approved prescription medication dispensed by a licensed pharmacy.

See all questions

Wegovy® is FDA-approved for chronic weight management. No specific outcomes are guaranteed; individual results may vary.

Wegovy® is a registered trademark of Novo Nordisk A/S. The Elysium Longevity Institute is not affiliated with, endorsed by, or sponsored by Novo Nordisk.

You may also like

Explore other treatments

  • Zepbound® (tirzepatide)
    Weight management

    Zepbound® (tirzepatide)

    Prefilled pen, subcutaneous · $750/mo

    View
  • Mounjaro® (tirzepatide)
    Weight management

    Mounjaro® (tirzepatide)

    Prefilled pen, subcutaneous · $1,620/mo

    View
  • Ozempic® (semaglutide)
    Weight management

    Ozempic® (semaglutide)

    Prefilled pen, subcutaneous · $780/mo

    View

Ready to start Wegovy® (semaglutide)?

Complete your intake online. A licensed provider will review your information and, if eligible, prescribe a personalized plan.

Get started

Wegovy® (semaglutide)

From $580/mo · Prefilled pen, subcutaneous

Get started

Personalized longevity care, guided by licensed providers.

Protocols

Cellular health Peptides Weight management

Company

How it works Scientific Advisory Board About Elysium

Support

Contact us FAQ BMI calculator Help center

Legal

Important Safety Information Privacy Policy Consumer Health Data Privacy Policy Terms of Service Your Privacy Choices

The information provided on this website is for general educational purposes only and is not medical advice. Elysium Health is not a clinical provider but contracts with third-party clinical entities with licensed health care providers which provide medical care to individuals that use the Elysium Health platform. Those providers determine whether treatment is clinically appropriate. Prescription products are available only upon evaluation and, if prescribed, fulfillment by a licensed pharmacy. Certain medications are compounded pursuant to a valid prescription and are not reviewed or approved by the FDA for safety, effectiveness, or quality. Individual results may vary. No specific outcomes are guaranteed. This service is not for medical emergencies — if you are experiencing an emergency, call 911.

© 2026 TELI by Elysium Health. All rights reserved.